Genes News and Research

RSS

Single gene defines difference between aggressive and non-aggressive forms of thymoma

For a rare form of cancer called thymoma, researchers have discovered a single gene defining the difference between a fast-growing tumor requiring aggressive treatment and a slow-growing tumor that doesn't require extensive therapy.

30 Jun 2014

CNIO researchers identify over 40 genes that predict aggressiveness of melanoma

Researchers from the Spanish National Cancer Research Centre have discovered more than 40 genes that predict the level of aggressiveness of melanoma and that distinguish it from other cancers with a poor prognosis. The discovery, published in Cancer Cell, will help to identify unique aspects of melanoma that could contribute to determine the risk of developing metastasis in patients with this disease.

28 Jun 2014

Gene study reveals the root of language development in humans

The evolution of language in humans continues to perplex scientists and linguists who study how humans learn to communicate.

28 Jun 2014

Autism Speaks awards more than $600,000 to scientists pursuing training in translational research

Autism Speaks, the world's leading autism science and advocacy organization, today announced it has awarded more than $600,000 in funding for six promising scientists pursuing academic training in translational research.

28 Jun 2014

Autism Speaks awards new research grants to advance understanding of autism subtypes

Autism Speaks, the world's leading autism science and advocacy organization, today announced the awarding of three new targeted research grants totaling more than $1 million.

28 Jun 2014

Child maltreatment increases vulnerability to alcohol consumption when reaching adolescence

A study coordinated by Jorge Manzanares, Professor of Pharmacology at the University Miguel Hernández (UMH) in Elche (Spain), shows that child maltreatment, whatever its form, produces functional brain changes that increase vulnerability to alcohol consumption when reaching adolescence.

28 Jun 2014

Some cancer patients with aggressive tumors may benefit from anti-inflammatory drugs

New research raises the prospect that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs used to treat rheumatoid arthritis.

28 Jun 2014

Vertex receives positive opinion from European CHMP for approval of KALYDECO for cystic fibrosis

Vertex Pharmaceuticals Incorporated today announced that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight non-G551D gating mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

28 Jun 2014

Researchers find way to diagnose aggressiveness of oral cancer

Studying mouth cancer in mice, researchers have found a way to predict the aggressiveness of similar tumors in people, an early step toward a diagnostic test that could guide treatment, according to researchers at Washington University School of Medicine in St. Louis.

28 Jun 2014

Non-Hodgkin lymphoma subgroups found to have different survival rates

A Mayo Clinic-led group of researchers has discovered three subgroups of a single type of non-Hodgkin lymphoma that have markedly different survival rates. These subgroups could not be differentiated by routine pathology but only with the aid of novel genetic tests, which the research team recommends giving to all patients with ALK-negative anaplastic large-cell lymphoma (ALCL). Findings are published in the journal Blood.

27 Jun 2014

Cancer drug shows promise in treating blood cell disorders

Scientists working to make gene therapy a reality have solved a major hurdle: how to bypass a blood stem cell's natural defenses and efficiently insert disease-fighting genes into the cell's genome.

27 Jun 2014

FMM supports research project to investigate mitochondria-targeted therapeutic approach

The Foundation for Mitochondrial Medicine announced today that it is working with The Michael J. Fox Foundation for Parkinson's Research to support a research project led by Wolfdieter Springer, PhD, at the Department of Neuroscience at Mayo Clinic in Florida to investigate a mitochondria-targeted therapeutic approach to treating Parkinson's disease.

26 Jun 2014

Foundation Medicine provides assistance to cancer patients, families seeking access to targeted therapies

Foundation Medicine, Inc. today announced that it has partnered with Patient Advocate Foundation (PAF) on a national program to provide assistance to patients with cancer and their families seeking access to targeted therapies.

26 Jun 2014

Current sequencing protocols overlook DNA crucial to bacterial virulence

Genomic sequencing is supposed to reveal the entire genetic makeup of an organism. For infectious disease specialists, the technology can be used to analyze a disease-causing bacterium to determine how much harm it is capable of causing and whether or not it will be resistant to antibiotics.

26 Jun 2014

Researchers compare genome sequences of malaria vectors to investigate insecticide resistance

Researchers from LSTM have exploited a natural experiment created by insecticidal pressure to determine how the most important malaria vectors - A. gambiae s.s. and A. coluzzii - respond rapidly to environmental change.

26 Jun 2014

USAMRIID scientists propose new standards to sequence viral genomes

Scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have proposed a set of standards aimed at developing a common "language" among investigators working to sequence viral genomes and characterize viral stocks.

26 Jun 2014

Study explains why people with disrupted circadian rhythms can be more susceptible to cancer

Research led by the University of Warwick's Systems Biology Centre and Medical School in collaboration with groups in Nice and Rotterdam has been able to demonstrate how the cycle of cell division in mammalian cells synchronises with the body's own daily rhythm, its circadian clock.

26 Jun 2014

Genes News and Research

Single gene defines difference between aggressive and non-aggressive forms of thymoma

CNIO researchers identify over 40 genes that predict aggressiveness of melanoma

Gene study reveals the root of language development in humans

Autism Speaks awards more than $600,000 to scientists pursuing training in translational research

Autism Speaks awards new research grants to advance understanding of autism subtypes

Child maltreatment increases vulnerability to alcohol consumption when reaching adolescence

Some cancer patients with aggressive tumors may benefit from anti-inflammatory drugs

Vertex receives positive opinion from European CHMP for approval of KALYDECO for cystic fibrosis

Researchers find way to diagnose aggressiveness of oral cancer

Non-Hodgkin lymphoma subgroups found to have different survival rates

Cancer drug shows promise in treating blood cell disorders

FMM supports research project to investigate mitochondria-targeted therapeutic approach

Foundation Medicine provides assistance to cancer patients, families seeking access to targeted therapies

Current sequencing protocols overlook DNA crucial to bacterial virulence

Researchers compare genome sequences of malaria vectors to investigate insecticide resistance

USAMRIID scientists propose new standards to sequence viral genomes

Study explains why people with disrupted circadian rhythms can be more susceptible to cancer

Women who give birth later in life tend to live longer

Gene partnership may be fueling cancer spread in as much as 20% of cancers

Researchers discover primordial cancer in primitive and evolutionary old animals

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics